Penn Medicine’s E. Michael Ostap, PhD, a professor of Physiology and director of the Pennsylvania Muscle Institute, and Qi Long, PhD, a professor of Biostatistics in the Department of Biostatistics, Epidemiology and Informatics, director of the Center for Cancer Data Science, and associate director for cancer informatics of the Penn Institute for Biomedical Informatics, have been named 2020 Fellows of the American Association for the Advancement of Science (AAAS).
PHILADELPHIA — Penn Medicine’s E. Michael Ostap, PhD, and Qi Long, PhD, have been named 2020 Fellows of the American Association for the Advancement of Science (AAAS) for their distinguished efforts toward advancing science and maintaining the highest standards of professional ethics and scientific integrity.
This year, 489 AAAS members have been selected as fellows by their peers because of their “scientifically or socially distinguished efforts to advance science or its applications.”
E. Michael Ostap, PhD, professor of Physiology and director of the Pennsylvania Muscle Institute, is being recognized for his contributions to the fields of biophysics and biochemistry, particularly for using single-molecule and biochemical techniques to study cytoskeletal motors. The Ostap Laboratory studies the molecules responsible for powering cell movements and shaping the architecture of cells and tissues. Recent work also includes investigating the motor proteins responsible for pumping the heart and characterizing drugs and disease-causing mutations that affect cardiac contractility.
“It is especially nice to be recognized for our basic science approach,” Ostap said. “It is wonderful to work in an environment here at Penn that appreciates that molecular details matter when trying to understand normal and abnormal physiology. Many thanks to my lab colleagues and collaborators.”
Qi Long, PhD, professor of Biostatistics in the Department of Biostatistics, Epidemiology and Informatics, director of the Center for Cancer Data Science, and associate director for cancer informatics of the Penn Institute for Biomedical Informatics, is being credited for his contributions to analysis of incomplete data, causal inference, and analysis of big data for advancing precision health. In addition to being named a Fellow for the AAAS, Long is an elected fellow of the American Statistical Association and an elected member of the International Statistical Institute.
“I am deeply honored by this recognition of our research in health data science,” Long said. “Penn has provided a highly supportive environment for us to accelerate innovations in health data science which play a vital role in advancing biomedical research and transforming precision health. I am very grateful for the valuable contributions from the current and former members of my research group and to my colleagues and collaborators at Penn.”
The AAAS is the world’s largest general scientific society and includes more than 250 affiliated societies and academies of science. Founded in 1848, the AAAS has maintained the tradition of naming Fellows since 1874. This year members were awarded this honor, nominated either through the steering groups of the association’s 24 sections, or by current AAAS members or the AAAS chief executive officer. Members are considered for the esteemed Fellows title if they have had continuous involvement with the organization for four years.
The AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on November 27, followed by a virtual induction ceremony for the new Fellow on February 13.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.